Quick Answer
CUMBERLAND PHARMACEUTICALS INC reported Stockholders Equity of $24.88 million for fiscal year 2025.
CUMBERLAND PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $24.88M | +8.9% |
| 2024 | $22.85M | -22.8% |
| 2023 | $29.60M | -18.4% |
| 2022 | $36.27M | -15.3% |
| 2021 | $42.81M | -8.9% |
| 2020 | $46.99M | -8.1% |
| 2019 | $51.12M | -8.5% |
| 2018 | $55.84M | -12.9% |
| 2017 | $64.12M | -12.5% |
| 2016 | $73.25M | -4.7% |
| 2015 | $76.89M | -4.8% |
| 2014 | $80.76M | +1.6% |
| 2013 | $79.47M | -7.3% |
| 2012 | $85.70M | +3.3% |
| 2011 | $82.93M | +6.6% |
| 2010 | $77.78M | +7.7% |
| 2009 | $72.22M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.12M | +5.4% | -6.7% |
| June 30, 2025 | $27.99M | +6.2% | -2.3% |
| March 31, 2025 | $28.66M | +4.2% | +25.4% |
| December 31, 2024 | $22.85M | -22.8% | -7.8% |
| September 30, 2024 | $24.78M | -31.2% | -6.0% |
| June 30, 2024 | $26.35M | -29.1% | -4.1% |
| March 31, 2024 | $27.49M | -24.4% | -7.1% |
| December 31, 2023 | $29.60M | -18.4% | -17.7% |
- CUMBERLAND PHARMACEUTICALS INC showed an increase of +8.9% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2025 period, CUMBERLAND PHARMACEUTICALS INC’s stockholders equity has declined by 65.5% (from $72.22 million to $24.88 million).
- The most recent figure is from CUMBERLAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: